Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Baxter International (NY: BAX )

36.51 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24
Open 36.51
Bid (Size) 36.05 (5)
Ask (Size) 36.52 (1)
Prev. Close 36.51
Today's Range 36.51 - 36.51
52wk Range 31.01 - 50.21
Shares Outstanding 499,910,255
Dividend Yield 3.18%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Is Nuvo Group (NUVO) Stock Up 200% Today?
Although prenatal care specialist Nuvo Group saw its shares soar on Monday, NUVO stock faces skepticism over its SPAC merger. 
Via InvestorPlace
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?
Stock spinoffs can unlock shareholder value but management sometimes uses them to get rid of unwanted, slow-growing businesses. 
Via InvestorPlace

Performance

YTD
-6.02%
-6.02%
1 Month
-13.59%
-13.59%
3 Month
-5.24%
-5.24%
6 Month
+5.86%
+5.86%
1 Year
-19.95%
-19.95%

More News

Read More
Why Is Medical Device Maker Baxter Stock Trading Lower On Thursday?
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
3 Dividend Stocks For 10%+ Annual Returns
Via Talk Markets
Assessing Baxter Intl: Insights From 4 Financial Analysts
Via Benzinga
Earnings Scheduled For February 8, 2024
Via Benzinga
Baxter International Inc. (NYSE: BAX) Highlighted for Surprising Price Action
Via Investor Brand Network
Baxter Reports First-Quarter 2024 Results
From Baxter International Inc.
Via Business Wire
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump System
Via Benzinga
Exposures Product Safety
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
From Baxter International Inc.
Via Business Wire
Baxter to Host Annual Meeting of Stockholders in Virtual Format
From Baxter International Inc.
Via Business Wire
Becton, Dickinson And Co. Dividend Stock Analysis
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Are Dialysis Provider Stocks Trading Higher On Tuesday?
Via Benzinga
Baxter to Present at Raymond James 45th Annual Institutional Investors Conference
From Baxter International Inc.
Via Business Wire
Stock Market Commentary: “Volumes Are The Name Of The Game…”
Via Talk Markets
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Barclays Maintains Overweight Rating for Baxter Intl: Here's What You Need To Know
Via Benzinga
Baxter Says 2023 Performance Reflects Strategic Initiatives With New Operating Model Without BioPharma Solutions Unit
Via Benzinga
Baxter Reports Fourth-Quarter and Full-Year 2023 Results
From Baxter International Inc.
Via Business Wire
Top Picks 2024: Baxter International
Via Talk Markets
Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.